News
$Moleculin Biotech(MBRX.US$ Reuters· 1 min ago
Moleculin Announces U.S. Patent Issue Notification for Lipid-Based Delivery Technology for Annamycin
Moleculin Announces U.S. Patent Issue Notification for Lipid-Based Delivery Technology for Annamycin
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
TrytosaveabitOP : Moleculin Biotech Inc - Annamycin Is Advancing Towards Pivotal Aml Study in 2024 and May Qualify for an Accelerated Approval Pathway